Validation of the Screening Instrument: PRISMA-7 for Frailty Among Elderly Hospitalized Danes

Frailty Syndrome Clinical Trial

Official title:

Validation of the Screening Instrument: PRISMA-7 for Frailty Among +75 Year Old Danes Still in Need of Physical Training When They Are Sent Home After a Hospital Stay

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT03999047
• Other study ID #: REG-070-2017
• Secondary ID: 707462
• Status: Active, not recruiting
• Start date: June 16, 2019
• Est. completion date: December 31, 2022

Study information

• Verified date: June 2019
• Source: Region Zealand
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The questionnaire PRISMA-7 was originally developed to assess frailty in community dwelling adults. The questionnaire was translated into the Danish language. This instrument was used to screen for frailty among elderly patients (75+) sent home from Nykøbing Falster Hospital after a hospital admission during the period 31. May 2017 until December 31st, 2018. PRISMA results were used to categorize each individula as frail or non-frail. The register of PRISMA results was merged with national registers on use of health serviced in order to investigate if increasing PRISMA score was associated with increasing use of health services.

Description:

Data from PRISMA scores were registered in an EasyTrial database. This database is recognized by the regional health authorities as a safe system to store individual health data. All use of the EasyTRial database is logged. The merging of data from the local EasyTRial database with data from national registries on use of health services and on mortality was permitted by the Danish National Health Data protection authorities.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 1050
• Est. completion date: December 31, 2022
• Est. primary completion date: December 31, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 75 Years and older

Eligibility

Inclusion Criteria:

• 75 years old persons being returned from hospital after a hospital admission and in need of further physical rehabilitation in the community

Exclusion Criteria:

Not able to give informed consent or if necessary not having a relative that can give informed consent

Related Conditions & MeSH terms

• Frailty
• Frailty Syndrome

Intervention

Diagnostic Test:
• PRISMA score
Screening for frailty using PRISMA-7

Locations

Country	Name	City	State
Denmark	Nykøbing Falster Hospital	Nykøbing Falster

Sponsors (2)

Lead Sponsor	Collaborator
Region Zealand	University of Southern Denmark

Country where clinical trial is conducted

Denmark, 

References & Publications (8)

Andersen JS, Olivarius Nde F, Krasnik A. The Danish National Health Service Register. Scand J Public Health. 2011 Jul;39(7 Suppl):34-7. doi: 10.1177/1403494810394718. — View Citation

Braun T, Grüneberg C, Thiel C. German translation, cross-cultural adaptation and diagnostic test accuracy of three frailty screening tools : PRISMA-7, FRAIL scale and Groningen Frailty Indicator. Z Gerontol Geriatr. 2018 Apr;51(3):282-292. doi: 10.1007/s00391-017-1295-2. Epub 2017 Aug 9. — View Citation

Hébert R, Durand PJ, Dubuc N, Tourigny A; PRISMA Group. Frail elderly patients. New model for integrated service delivery. Can Fam Physician. 2003 Aug;49:992-7. — View Citation

Hoogendijk EO, van der Horst HE, Deeg DJ, Frijters DH, Prins BA, Jansen AP, Nijpels G, van Hout HP. The identification of frail older adults in primary care: comparing the accuracy of five simple instruments. Age Ageing. 2013 Mar;42(2):262-5. doi: 10.1093/ageing/afs163. Epub 2012 Oct 28. — View Citation

Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011 Jul;39(7 Suppl):38-41. doi: 10.1177/1403494810394717. — View Citation

Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011 Jul;39(7 Suppl):30-3. doi: 10.1177/1403494811401482. — View Citation

Raîche M, Hébert R, Dubois MF. PRISMA-7: a case-finding tool to identify older adults with moderate to severe disabilities. Arch Gerontol Geriatr. 2008 Jul-Aug;47(1):9-18. Epub 2007 Aug 27. — View Citation

Turner G, Clegg A; British Geriatrics Society; Age UK; Royal College of General Practioners. Best practice guidelines for the management of frailty: a British Geriatrics Society, Age UK and Royal College of General Practitioners report. Age Ageing. 2014 Nov;43(6):744-7. doi: 10.1093/ageing/afu138. Review. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Mortality	Mortality	6 months after PRISMA-7 screening
Primary	Morbidity	Morbidity will be measured by registering Hospital admissions and use of general practitioner	6 months after Prisma-7 screening
Secondary	Use of other health services	Home help, rehabilitation services in the municipality	6 months before PRISMA-7 screening
Secondary	Morbidity	Morbidity will be measured by registering hospital admissions and use og general practitioner	6 months after PRISMA-7 screening